Josias Pontes serves as Executive at Sigilon Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Josias Pontes has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Aug 11, 2023 involved selling 3,504 shares valued at $0.
Josias Pontes currently holds 3,254 shares of Sigilon Therapeutics, Inc. (SGTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Josias Pontes has been a net neutral trader of SGTX stock. They have purchased $0 and sold $0 worth of shares.
Josias Pontes's most recent insider trade was on Aug 11, 2023, when they sold 3,504 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| 1,444 |
| $19.24 |
| Discretionary |
| Sep 30, 2021 | SGTX | $0 | Award | 11,500 | $N/A | Discretionary |